title: [Autoimmune pancreatitis: beneficial effects of corticosteroid therapy on biliary and metabolic complications].
abstract: Auto-immune pancreatitis is rare and its evolution includes both the usual complications of chronic pancreatites, such as diabetes and specific consequences and complications including extension of inflammatory lesions of the extra or intrahepatic biliary tract. One particular characteristic of these complications is that they are sensitive to cortisone therapy, as illustrated by the case we report here.
authors.affiliation: Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Lyon.
authors.forename: Ivan
authors.initials: I
authors.lastname: Graber
authors.forename: Annick
authors.initials: A
authors.lastname: Chavaillon
authors.forename: Frank
authors.initials: F
authors.lastname: Pilleul
authors.forename: Christian
authors.initials: C
authors.lastname: Partensky
authors.forename: Thierry
authors.initials: T
authors.lastname: Ponchon
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Valette
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Scoazec
authors.forename: Jérôme
authors.initials: J
authors.lastname: Dumortier
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D049448:Cholangiopancreatography, Magnetic Resonance; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000175:diagnosis / Q000209:etiology; D002779:Cholestasis / Q000150:complications / Q000175:diagnosis / Q000209:etiology; D002908:Chronic Disease; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000175:diagnosis / Q000209:etiology; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone